Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity

Cancer Research

Volumn 62, Issue 23, 2002, Pages 6944-6951

  Greiner, John W ^a   Zeytin, Hasan ^a   Anver, Miriam R ^b   Schlom, Jeffrey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MACROPHAGE ACTIVATING FACTOR; RECOMBINANT PROTEIN; VACCINE;

ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNITY; BOLUS INJECTION; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; FOWLPOX VIRUS; GASTROINTESTINAL TRACT; GENE OVEREXPRESSION; HUMAN; IMMUNE RESPONSE; INTESTINE TUMOR; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; VACCINATION; VACCINIA; VILLOUS ADENOMA; VIRUS EXPRESSION; WEIGHT REDUCTION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS, CD58; ANTIGENS, CD80; AUTOIMMUNITY; BODY WEIGHT; CANCER VACCINES; CARCINOEMBRYONIC ANTIGEN; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOCRIT; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 0036897080     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Gold, P., and Freedman, S. O. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J. Exp. Med., 121: 439-462, 1965.
2. Thompson, J. A., Grunert, F., and Zimmermann, W. Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives. J. Lab. Clin. Anal., 5: 344-366, 1991.
3. Goldenberg, D. M., Kim, E. E., Deland, F. H., Bennett, S., and Primus, F. J. Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res., 40: 2984-2992, 1980.
4. McAneny, D., Ryan, C. A., Beazley, R. M., and Kaufman, H. L. Results of a Phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer. Ann. Surg. Oncol., 3: 495-500, 1996.
5. Samanci, A., Yi, Q., Fagerberg, J., Strigard, K., Smith, G., Ruden, U., Wahren, B., and Mellstedt, H. Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen. Cancer Immunol. Immunother., 47: 131-147, 1998.
6. Conry, R. M., Khazaeli, M. B., Saleh, M. N., Allen, K. O., Barlow, D. L., Moore, S. E., Craig, D., Arani, R. B., Schlom, J., and LoBuglio, A. F. Phase I trial of a recombinant vaccinia virus encoding carcinoembryonic antigen in metastatic adenocarcinoma: comparison of intradermal verzus subcutaneous administration. Clin. Cancer Res., 5: 2330-2337, 1999.
7. Marshall, J. L., Hawkins, M. J., Tsang, K. Y., Richmond, E., Pedicano, J. E., Zhu, M-Z., and Schlom, J. Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen. J. Clin. Oncol., 17: 332-337, 1999.
8. von Mehren, M., Arlen, P., Tsang, K. Y., Rogatko, A., Meropol, N., Cooper, H. S., Davey, M., McLaughlin, S., Schlom, J., and Weiner, L. Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas. Clin. Cancer Res., 6: 2219-2228, 2000.
9. Fong, L. H., Hou, Y., Rivas, A., Benicke, C., Yuen, A., Fisher, G. A., Davis, M. M., and Engleman, E. G. Altered peptide ligund vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy. Proc. Natl. Acad. Sci. USA, 98: 8809-8814, 2001.
10. Marshall, J. L., Hoyer, R. J., Toomey, M. A., Faraguna, K., Chang, P., Richmond, E., Pedicano, J. E., Gehan, E., Peck, R. A., Arlen, P., Tsang, K. Y., and Schlom, J. Phase I study in cancer patients of a diversified prime and boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J. Clin. Oncol., 18: 3964-3973, 2000.
11. Eades-Perner, A-M., van der Putten, H., Hirth, A., Thompson, J., Neumaier, M., von Kleist, S., and Zimmermann, W. Mice transgenic for the human carcinoembryonic antigen gene maintain its spatiotemporal expression pattern. Cancer Res., 54: 4169-4176, 1994,
12. Clarke, P., Mann, J., Simpson, J. F., Rickard-Dickson, K., and Primus, F. J. Mice transgenic for human carcinoembryonic antigen as a model for immunotherapy. Cancer Res., 58: 1469-1477, 1998.
13. Eades-Pemer, A-M., and Zimmermann, W. Carcinoembryonic antigen-transgenic mice: A model for tumor immunotherapy. Tumor Biol., 16: 56-61. 1995.
14. Kass, E., Schlom, J., Thompson, J., Guadagni, F., Graziano, P., and Greiner, J. Induction of protective host immunity to carcinoembryonic antigen (CEA), a self antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus. Cancer Res., 59: 676-683, 1999.
15. Kass, E., Panicali, D. L., Mazzara, G., Schlom, J., and Greiner, J. W. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant. Cancer Res., 61: 206-214, 2001.
16. Mizobata, S., Tompkins, K., Simpson, J. F., Shyr, Y., and Primus, F. P. Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen. Cancer Immunol. Immunother., 49: 285-295, 2000.
17. Niethammer, A. G., Primus, F. J., Xiang, R., Dolman, C. S., Ruehlmann, J. M., Ba, Y., Gillies, S. D., and Reisfeld, R. A. An oral DNA vaccine against human carcino-embryonic antigen (CEA) prevents growth and dissemination of Lewis lung carcinoma in CEA transgenic mice. Vaccine, 20: 421-429, 2001.
18. Xiang, R., Primus, F. J., Ruehlmann, J. M., Niethammer, A. G., Silletti, S., Lode, H. N., Dolman, C. S., Gillies, S. D., and Reisfeld, R. A. A dual-function DNA vaccine encoding carcinoembryonic antigen and CD40 ligand trimer induces T-cell-mediated protective immunity against colon cancer in carcinoembryonic antigen-transgenic mice. J. Immunol., 167: 4560-4565, 2001.
19. Moser, A. R., Pitot, H. C., and Dove, W. F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science (Wash. DC), 247: 322-324, 1990.
20. Su, L-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C. V., Gould, K. A., and Dove, W. F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science (Wash. DC), 256: 668-670, 1992.
21. Thompson, J. A., Eades-Perner, A-M., Ditter, M., Muller, W. J., and Zimmermann, W. Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: An animal model for CEA-directed tumor immunotherapy. Int. J. Cancer, 72: 197-202, 1997.
22. Wilkinson, R. W., Ross, E. L., Poulsom, R., Iiyas, M., Straub, J., Snary, D. Bodmer, W. F., and Mather, S. J. Antibody targeting studies in a transgenic murine model of spontaneous colorectal tumors. Proc. Natl. Acad. Sci., USA. 98: 10256-10260, 2001.
23. Hodge, J. W., Sabzevari, H., Yafal, A. G., Gritz, L., Lorenz, M. G. O., and Schlom, J. A triad of costimulatory molecules synergize to amplify T-cell activation. Cancer Res., 59: 5800-5807, 1999.
24. Paulsen, J. E., Steffensen, I-L., Andreassen, A., Vikse, R., and Alexander, J. Neonatal exposure to the food mutagen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis (Lond.), 20: 1277-1282, 1999.
25. Grosenbach, D. W., Barrientos, J. C., Schlom, J., and Hodge, J. W. Synergy of vaccine strategies to amplify antigen-specific immune responses and antitumor effects. Cancer Res., 61: 4497-4505, 2001.
26. Colcher, D., Bird, R., Roselli, M., Hardman, K. D., Johnson, S., Pope, S., Dodd, S. W., Pantoliano, M. W., Milenic, D. E., and Schlom, J. In vivo tumor targeting of a recombinant single-chain antigen binding protein. J. Natl. Cancer Inst. (Bethesda), 82: 1191-1197, 1990.
27. Muraro, R., Wunderlich, D., Thor, A., Lundy, J., Noguchi, P., Cunningham, R., and Schlom, J. Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinoma versus normal adult tissues. Cancer Res., 45: 5769-5780, 1985.
28. Guadagni, F., Witt, P. L., Robbins, P. F., Schlom, J., and Greiner, J. W. Regulation of carcinoembryonic antigen expression in different human colorectal tumor cells by interferon-γ. Cancer Res., 50: 6248-6255, 1990.
29. Schmitz, J., Schlom, J., Reali, E., Hodge, J. W., Patel, A., Davis, G., and Greiner J. W. Identification of an interferon-γ-inducible carcinoembryonic antigen (CEA) CD8+ T-cell epitope which mediates tumor killing in CEA transgenic mice. Cancer Res., 62: 5058-5064, 2002.
30. Paulsen, J. E., Steffensen, I-L., Loberg, E. M., Husoy, T., Namork, E., and Alexander, J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res., 61: 5010-5015, 2001.
31. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
32. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., Aoki, T., Miki, Y., Mori, T., and Nakamura, Y. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene. Hum. Mol. Genet., 1: 229-233, 1992.
33. Guadagni, F., Roselli, M., Cosimelli, M., Spila, A., Cavaliere, F., Arcuri, R., D'Alessandro, R., Fracasso, P. L., Casale, V., Vecchione, A., Casciani, C. U., Greiner, J. W., and Schlom, J. Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation. Int. J. Cancer, 72: 949-954, 1997.
34. Smith, G. L., and Moss, B. Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA. Gene (Amst.), 25: 21-28, 1983.
35. Stephens, E. B., Compans, R. W., Earle, P., and Moss, B. Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J., 5: 237-245, 1986.
36. Hodge, J. W., McLaughlin, J. P., Kantor, J. A., and Schlom, J. Diversified prime and boost protocols using recombinant vaccinia virus and recombinant non-replicating avian pox virus to enhance T-cell immunity and antitumor responses. Vaccine, 15: 759-768, 1997.
37. Kielian, T., Nagai, E., Ikubo, A., Rasmussen, C. A., and Suzuki, T. Granulocyte/macrophage-colony-stimulating factor released by adenovirally transduced CT26 cells leads to the local expression of macrophage inflammatory protein 1α and accumulation of dendritic cells at vaccination sites in vivo. Cancer Immunol. Immunother., 48: 123-131, 1999.
38. Moser, A. R., Dove, W. F., Roth, K. A., and Gordon, J. I. The Min (Multiple Intestinal Neoplasia) mutation: Its effects on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol., 116: 1517-1526, 1992.
39. Fong, L., Ruegg, C. L., Brockstedt, D., Engleman, E. G., and Laus, R. Induction of tissue-specific autoimmune prostatitis with prostatic acid phosphatase immunization. J. Immunol., 159: 3113-3117, 1997.
40. Dittel, B. N., Visintin, I., Merchant, R. M., and Janeway, C. A., Jr. Presentation of the self antigen myelin basic protein by dendritic cells leads to experimental autoimmune encephalomyelitis. J. Immunol., 163: 32-39, 1999.
41. Overwijk, W. W., Lee, D. S., Surman, D. R., Irvine, K. R., Touloukian, C. E., Chan, C-C., Carroll, M. W., Moss, B., Rosenberg, S. A., and Restifo, N. P. Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: Requirement for CD4+ T lymphocytes. Proc. Natl. Acad. Sci. USA, 96: 2982-2987, 1999.
42. Ludewig, B., Ochsenbein, A. F., Odermatt, B., Paulin, D., Hengartner, H., and Zinkemagel, R. M. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med., 191: 795-803, 2000.
43. Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA. 90: 3539-3543, 1993.
44. van Elsas, A., Sutmuller, R. P. M., Hurwitz, A. A., Ziskin, J., Villasenor, J., Medema, J-P., Overwij, W. W., Restifo, N. P., Melief, C. J. M., Offringa, R., and Allison, J. P. Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy. J. Exp. Med., 194: 481-489, 2001.
45. Gilboa, E. The risk of autoimmunity associated with tumor immunotherapy. Nat. Immune., 2: 789-792, 2001.